216 related articles for article (PubMed ID: 9452343)
1. Comparison of treatment of tardive dystonia and idiopathic cervical dystonia with botulinum toxin type A.
Brashear A; Ambrosius WT; Eckert GJ; Siemers ER
Mov Disord; 1998 Jan; 13(1):158-61. PubMed ID: 9452343
[TBL] [Abstract][Full Text] [Related]
2. Quantitative assessment of botulinum toxin treatment in 43 patients with head tremor.
Wissel J; Masuhr F; Schelosky L; Ebersbach G; Poewe W
Mov Disord; 1997 Sep; 12(5):722-6. PubMed ID: 9380055
[TBL] [Abstract][Full Text] [Related]
3. BotB (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study).
Truong DD; Cullis PA; O'Brien CF; Koller M; Villegas TP; Wallace JD
Mov Disord; 1997 Sep; 12(5):772-5. PubMed ID: 9380065
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin and neuromotor rehabilitation: An integrated approach to idiopathic cervical dystonia.
Tassorelli C; Mancini F; Balloni L; Pacchetti C; Sandrini G; Nappi G; Martignoni E
Mov Disord; 2006 Dec; 21(12):2240-3. PubMed ID: 17029278
[TBL] [Abstract][Full Text] [Related]
5. Fast voluntary neck movements in patients with cervical dystonia: a kinematic study before and after therapy with botulinum toxin type A.
Gregori B; Agostino R; Bologna M; Dinapoli L; Colosimo C; Accornero N; Berardelli A
Clin Neurophysiol; 2008 Feb; 119(2):273-80. PubMed ID: 18063411
[TBL] [Abstract][Full Text] [Related]
6. Change in lateralization of the P22/N30 cortical component of median nerve somatosensory evoked potentials in patients with cervical dystonia after successful treatment with botulinum toxin A.
Kanovský P; Streitová H; Dufek J; Znojil V; Daniel P; Rektor I
Mov Disord; 1998 Jan; 13(1):108-17. PubMed ID: 9452335
[TBL] [Abstract][Full Text] [Related]
7. Variability of the immunologic and clinical response in dystonic patients immunoresistant to botulinum toxin injections.
Sankhla C; Jankovic J; Duane D
Mov Disord; 1998 Jan; 13(1):150-4. PubMed ID: 9452341
[TBL] [Abstract][Full Text] [Related]
8. Clinical changes of cervical dystonia pattern in long-term botulinum toxin treated patients.
Maia FM; Kanashiro AK; Chien HF; Gonçalves LR; Barbosa ER
Parkinsonism Relat Disord; 2010 Jan; 16(1):8-11. PubMed ID: 19589716
[TBL] [Abstract][Full Text] [Related]
9. A prospective, randomized, double-blind study comparing the efficacy and safety of type a botulinum toxins botox and prosigne in the treatment of cervical dystonia.
Quagliato EM; Carelli EF; Viana MA
Clin Neuropharmacol; 2010; 33(1):22-6. PubMed ID: 19959960
[TBL] [Abstract][Full Text] [Related]
10. Factors affecting the health-related quality of life of patients with cervical dystonia and the impact of botulinum toxin type A injections.
Slawek J; Friedman A; Potulska A; Krystkowiak P; Gervais C; Banach M; Ochudlo S; Budrewicz S; Reclawowicz D; Rynkowski M; Opala G
Funct Neurol; 2007; 22(2):95-100. PubMed ID: 17637212
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of cervical dystonia patients treated with botulinum toxin A.
Haussermann P; Marczoch S; Klinger C; Landgrebe M; Conrad B; Ceballos-Baumann A
Mov Disord; 2004 Mar; 19(3):303-8. PubMed ID: 15022184
[TBL] [Abstract][Full Text] [Related]
12. Extensor truncal dystonia: successful treatment with botulinum toxin injections.
Comella CL; Shannon KM; Jaglin J
Mov Disord; 1998 May; 13(3):552-5. PubMed ID: 9613753
[TBL] [Abstract][Full Text] [Related]
13. Long-term botulinum toxin efficacy, safety, and immunogenicity.
Mejia NI; Vuong KD; Jankovic J
Mov Disord; 2005 May; 20(5):592-7. PubMed ID: 15645481
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
15. Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm.
Bihari K
Curr Med Res Opin; 2005 Mar; 21(3):433-8. PubMed ID: 15811212
[TBL] [Abstract][Full Text] [Related]
16. Natural history of posttraumatic cervical dystonia.
Frei KP; Pathak M; Jenkins S; Truong DD
Mov Disord; 2004 Dec; 19(12):1492-8. PubMed ID: 15390063
[TBL] [Abstract][Full Text] [Related]
17. Improvement in quality of life after botulinum toxin-A injections for idiopathic detrusor overactivity: results from a randomized double-blind placebo-controlled trial.
Sahai A; Dowson C; Khan MS; Dasgupta P
BJU Int; 2009 Jun; 103(11):1509-15. PubMed ID: 19389019
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin A--injection for cervical dystonia.
Bhaumik S; Behari M
J Assoc Physicians India; 1999 Mar; 47(3):267-70. PubMed ID: 10999117
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of repeated doses of botulinum toxin type B in type A resistant and responsive cervical dystonia.
Factor SA; Molho ES; Evans S; Feustel PJ
Mov Disord; 2005 Sep; 20(9):1152-60. PubMed ID: 15954134
[TBL] [Abstract][Full Text] [Related]
20. The impact of blepharospasm and cervical dystonia on health-related quality of life and depression.
Müller J; Kemmler G; Wissel J; Schneider A; Voller B; Grossmann J; Diez J; Homann N; Wenning GK; Schnider P; Poewe W;
J Neurol; 2002 Jul; 249(7):842-6. PubMed ID: 12140667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
